| Document |
Document Title |
|
JP4743673B2 |
Novel conformationally restricted polyamine analogs are provided, as well as compositions comprising these novel polyamine analogs. Methods of using the novel polyamine analogs in treatment of diseases such as cancer are also provided. A...
|
|
JP4733334B2 |
Methods are disclosed for producing electrochemiluminescence by electrochemically oxidizing an acridan compound at an electrode in the presence of a peroxide. Maintaining a sufficiently positive potential results in continuous oxidation ...
|
|
JP4699756B2 |
In accordance with the present invention, it has been discovered that introduction of hydrophilic sulfoalkyl substituents and/or hydrophilic linkers derived from homocysteic acid, cysteic acid, glycine peptides, tetraethylene oxide, and ...
|
|
JP4686126B2 |
Novel compounds comprising a C-C double bound substituted at one carbon with two sulphur atom-containing groups are disclosed. The compounds are useful in methods and compositions for generating chemiluminescence rapidly by reaction with...
|
|
JP4683675B2 |
Battery has an electrolyte comprising a solvent and a salt (I) comprising a hydroxonium, nitrosonium, ammonium, metal, organic or organometallic cation and a 5-membered (hetero)cyclic anion. Battery has an electrolyte comprising a solven...
|
|
JP2011084586A |
To develop novel polyamine analogues for various applications.The present invention provides novel polyamine analogues, compositions comprising these polyamine analogues, and methods of using the analogues and the compositions. In one em...
|
|
JP4672144B2 |
A method for the detection or quantitation of unlabeled target analyte in a biological sample, the method comprising labeling a target analyte for a biological sample suspected of containing unlabeled target analyte with an acridinium co...
|
|
JP2011075785A |
To provide an electrophotographic photoreceptor with excellent photo sensitivity and filming resistance.The electrophotographic photoreceptor including a photosensitive layer on a conductive substrate contains an acridone derivative repr...
|
|
JP4652054B2 |
A family of compounds of formula (I) wherein: X is one of the following radicals: which behaves as dual site acetyl-cholinesterase inhibitors and which are especially useful for the treatment of cognitive disorders as senile dementia, ce...
|
|
JP4653216B2 |
Provided are a novel transition metal complex where a monocyclopentadienyl ligand to which an amido group is introduced is coordinated, a catalyst composition including the same, and an olefin polymer using the catalyst composition. The ...
|
|
JP4646494B2 |
To obtain a new nitrogen-containing heterocyclic derivative useful as a constituent component for an organic electroluminescent element (organic EL element) and the organic EL element which attains high luminance, high luminescence effic...
|
|
JP2011026376A |
To provide a dye-sensitized type battery having high conversion efficiency by using an inexpensive organic dye.The dye has a structure expressed by general formula (1). In the formula, X represents an oxygen atom, a sulfur atom or CR2(R3...
|
|
JP4630405B2 |
The present invention relates to a system for use in treating a blood product containing a pathogen inactivating agent comprising a biocompatible housing and an adsorbent medium having (1) adsorbent resin particles capable of adsorbing t...
|
|
JP2011006559A |
To provide an inexpensive pigment compound capable of achieving a high photoelectric conversion ratio, accessible without remarkable restriction, a photoelectric conversion element and a solar battery using the same.The pigment compound ...
|
|
JP4601234B2 |
An organic electroluminescence device which exhibits an excellent purity of color and a high efficiency of light emission, has a long life and emits reddish light and a novel compound having these characteristics are provided. The organi...
|
|
JP4601293B2 |
Compounds having the formula (I), wherein R3 is selected from H, OH and NH2; R30 is selected from -O and -S; W is -C(-O)-, -S(-O)-, or -S(O)2-; or W may be -CH2- if X is -C(-O)-; X is selected from -CH2-, -N(R4)-, and -O-, except that wh...
|
|
JP2010280512A |
To provide an inorganic-organic composite material capable of attaining a charge-separated state enhanced in life and stability as compared with that of conventional inorganic-organic composite materials.The inorganic-organic composite m...
|
|
JP4585750B2 |
A new condensed polycyclic compound represented by general formula [I]: wherein R1 is hydrogen, halogen, cyano, a substituted amino or a group selected from the group consisting of alkyl, aralkyl, aryl, heterocyclic, each having no subst...
|
|
JP4583027B2 |
Disclosed are methods for assay of an analyte employing acridone dyes having the structure: Z1 and Z2 represent atoms necessary to complete one ring, two fused ring, three fused ring aromatic or heteroaromatic systems, each ring having f...
|
|
JP4573533B2 |
The present invention is concerned with radiolabelled quinoline and quinolinone derivatives according Formula (I-A)* or (I-B)* showing metabotropic glutamate receptor antagonistic activity, in particular mGlu1 receptor activity, and thei...
|
|
JP4570364B2 |
A novel chemiluminescent compound is provided. In one embodiment, the novel compound is employed in an assay to detect analytes. The assay to detect analytes includes the steps of binding the novel compound to the analyte and detecting t...
|
|
JP2010237226A |
To provide a method for the measurement of hydride using a chemiluminescent compound, such as an acridinium compound. The source of hydride may be of chemical or biochemical origin, or the result of enzymatic catalysis. The chemical sour...
|
|
JP2010215633A |
To identify two sets of necessary and sufficient criteria for observing long-wavelength emission from an acridinium compound.The two sets, i.e. set (A) and set (B), of necessary and sufficient criteria for observing long-wavelength emiss...
|
|
JP4551502B2 |
Compounds and methods for inactivating pathogens in materials are described, including compositions and methods for inactivating pathogens in biological materials such as red blood cell preparations and plasma. The compounds and methods ...
|
|
JP4546090B2 |
Compounds having the formula (I), wherein R3 is selected from H, OH and NH2; R30 is selected from -O and -S; W is -C(-O)-, -S(-O)-, or -S(O)2-; or W may be -CH2- if X is -C(-O)-; X is selected from -CH2-, -N(R4)-, and -O-, except that wh...
|
|
JP4542838B2 |
|
|
JP4536714B2 |
New color-forming enzyme substrates for detecting aminopeptidase activity in microorganisms, or for differentiating Gram positive and Gram negative bacteria, comprise 9-(phenyl, phenylethenyl or phenylbutadienyl)-acridine or acridinium c...
|
|
JP4531149B2 |
To obtain the subject medicine such as antiherpes viral agent exhibiting excellent antiviral activity and useful as a medicine by including a specific nitrogen-containing tri or tetracyclic compound. This antiviral agent contains a nitro...
|
|
JP4524186B2 |
A process for producing an arylamine is provided which is characterized by reacting an aromatic halogen compound with an aromatic amine in the presence of an organic salt selected from specific pyridinium salts, imidazolium salts and qua...
|
|
JP4503833B2 |
A method for stereochemically controlled production of azacyclic compounds of general formula (I) in which the substituents have the meanings given in the specification. The invention also relates to intermediate products of this method ...
|
|
JP2010132638A |
To provide a new organic electroluminescent compound and an organic electroluminescent element by using the same. This organic electroluminescent compound is expressed by chemical formula 1 [wherein, among Ar1, Ar2, R6, R7, R8, R9, R10, ...
|
|
JP2010520884A |
This invention is directed to, for example, compounds of formula (I): wherein n, m, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically accep...
|
|
JP4439265B2 |
This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, TNF-alpha or combinations thereof.
|
|
JP2010059141A |
To provide a process for simultaneously manufacturing an aromatic aldehyde and hydrogen peroxide and a new catalyst for the process.The aromatic aldehyde and the hydrogen peroxide can be simultaneously manufactured by irradiating a mixed...
|
|
JP2010059144A |
To provide a new organic electroluminescent compound and an organic electroluminescent device using it as an electroluminescent material.The compound is represented by chemical formula 1, (wherein, ring A and ring B indicate each indepen...
|
|
JP2010059158A |
To provide a new organic electroluminescent compound and an organic electroluminescent device, etc., containing the compound.The electroluminescent compound is expressed by chemical formula 1 (wherein R1 to R10 are each H or a substituen...
|
|
JP4431272B2 |
Novel compounds comprising a C-C double bond substituted at one carbon with two oxygen or sulfur atom-containing groups are disclosed. The compounds are useful in methods and compositions for generating chemiluminescence by reaction with...
|
|
JP4424026B2 |
To provide an organic electroluminescent element having high electric current efficiency and light-emitting efficiency, capable of being driven by a low voltage, having excellent driving stability and heat resistance, and having stable l...
|
|
JP2010031049A |
To provide a simpler, safer and more economic means for reducing the concentration of small organic compounds in a biological fluid while substantially maintaining biological activity of the purified fluid.The device reduces the concentr...
|
|
JP4408452B2 |
Fluoroionophores of formula (I)whereinR06 is H or substituted or unsubstituted C1-C20alkyl,R6 is H or substituted or unsubstituted C1-C30alkyl or C1-C30alkoxy,R1 is a bridging group, andF is a residue of a fluorophore.The fluoroionophore...
|
|
JP2010013444A |
To provide a new organic electroluminescent compound intended for achieving an organic electroluminescent device which is excellent in luminous efficiency and shows drastically increased life, and the organic electroluminescent device co...
|
|
JP2010006817A |
To provide a hydroxamic acid or carboxylic acid-functional compound (which can inhibit production of a tumor necrosis factor alpha (TNF-)), a pharmaceutical composition containing such a compound and a curing method using such a compound...
|
|
JPWO2008010400A1 |
In the present invention, a photosensitive layer containing (A) a polymerization initiator, (B) a polymerizable, ethylenic double bond-containing compound, (C) a sensitizing dye, and (D) a polymer binder on a support. The photosensitive ...
|
|
JP2009543872A |
This invention provides nuclear hormone receptor binding compounds, compositions comprising the same and methods of uses thereof in treating a variety of diseases or conditions in a subject, including, inter-alia, prostate cancer and/or ...
|
|
JP4361137B2 |
Battery has an electrolyte comprising a solvent and a salt (I) comprising a hydroxonium, nitrosonium, ammonium, metal, organic or organometallic cation and a 5-membered (hetero)cyclic anion. Battery has an electrolyte comprising a solven...
|
|
JP4351533B2 |
The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
|
|
JP4293474B2 |
Fluoroionophores that are functionalised with reactive groups and correspond to the formula I-R1-F-R2-G, wherein I is a monovalen residue of an ionophore, wherein F is a divalent residue of a fluorophore, wherein G is a functional group ...
|
|
JP2009102312A |
To provide a compound having excellent insecticidal activity that can be used as an insecticide for agricultural and horticultural applications.A compound represented by formula (I) and an agriculturally and horticulturally acceptable ac...
|
|
JP2009057303A |
To provide a therapeutic agent of central urinary disturbance, especially the therapeutic agent of the urinary disturbance associated with diseases such as Down's syndrome, cerebral infarction, after effects of encephalorrhagia and demen...
|
|
JP2009041027A |
To provide a fluorescent dye compound which is excitable by light having a wavelength above about 600 nm.The fluorescent dye compound is chemically and photoactively stable and is excitable by light having a wavelength above about 600 nm...
|
